OncoImmune is a clinical-stage company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer. Founded by Kun-Liang Guan, Ming You, Pan Zheng, and Yang Liu in 2000, OncoImmune is backed by investors that include GBA Fund, GF Xinde Investment Management, Kaitai Capital, HM Capital, and 3E Bioventures and is headquartered in Rockville.